Effectiveness of Two Different Methods During Intramuscular Antibiotic Injection: ShotBlocker, Local Vibration

NCT ID: NCT04851158

Last Updated: 2023-03-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-20

Study Completion Date

2021-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In intramuscular injection applications, which are among the responsibilities and basic skills of nurses, different methods are used to reduce the pain caused by injection and increase the individual's satisfaction. ShotBlocker and local vibration are among the methods used for this purpose. The aim of the study is to examine the effectiveness of ShotBlocker and local vibration, which are among the non-pharmacological methods, on the perceived pain and satisfaction during ventrogluteal intramuscular antibiotic injection.

This randomized, controlled experimental study will be carried out in the adult emergency clinic of a training and research hospital in Istanbul between February and April 2021.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of study was to evaluate four research hypotheses as follows:

H1: Using ShotBlocker during intramuscular antibiotic injection reduces the patient's injection pain.

H2: Using ShotBlocker during intramuscular antibiotic injection increases the patient's satisfaction with the injection.

H3: Using a local vibrator device during intramuscular antibiotic injection reduces the patient's injection pain.

H4: Using a local vibrator device during intramuscular antibiotic injection increases the patient's satisfaction with the injection.

Sampling of the Research: The sample number was determined at the 0.5 effect size and 0.05 error level with the power analysis performed by taking into account the numerical values of the findings obtained from a previous study on this subject. ShotBlocker group: 35; Local vibration group: 35, Control Group: 35 people.

The sample of the study will consist of volunteer patients who apply to the adult emergency department, who are administered antibiotics (amoxicillin / cefuroxime sodium) upon the physician's request, and who meet the inclusion criteria.

Data Collection Tools: Research data will be collected using the Structured Information Form created by the researchers, VAS Pain and VAS Satisfaction Scales.

Structured Information Form; Five questions regarding the descriptive characteristics of the participants (age, gender, body mass index (BMI), educational status, marital status) were included. BMI (kg/m2) of the participants will be calculated by the researcher.

Procedure:

1. Initial Assessment:

Verbal information will be given to the participants and their written consents will be obtained prior to the intramuscular injection. The "Structured Information Form" consisting of five questions will be applied by face to face interview method, BMI will be calculated by measuring height and weight and recorded in the "Structured Information Form".

ShotBlocker is a patented tool developed by Bionix (Toledo, OH, United States). It is a small, flat, horseshoe (U-shaped) shaped plastic tool with a thickness of 2 mm, which is used for pain control in intramuscular and subcutaneous injections, suitable for all age groups, has no known side effects, does not have drug properties, is non-invasive. Since it is not an invasive device, it is stated by the manufacturer that it can be used several times for the same patient after washing with soap. The protruding surface of the vehicle is placed in the area to be applied just before injection. Short blunt bumps on the surface of the vehicle do not pierce the skin.

Local Vibrator one of the electric vibrator devices (dolphin massager device, 210-240 V, 50 Hz) produced by different brands was used. These devices with interchangeable heads have the ability to affect deep muscle groups, stimulate nerve endings and accelerate blood circulation thanks to mechanical vibration. During application, the device must be in full contact with the skin. Local vibration application reduces perceived pain by stimulating nerve fibers according to Melzack and Wall's Gate Control Theory.
2. Application:

Before the drug is prepared, the physician's request will be checked by the researcher. Hands will be washed, the drug (amoxicillin / cefuroxime sodium) will be prepared by diluting with 4 ml of water for injection, the needle tip will be changed to 21G (0.8x40mm - green). The patient will be verbally informed, and the drug allergy status will be questioned. The patient will be asked to lie down in the prone position. The skin surface in the area where the IM injection will be applied will be observed by the researching specialist nurse for ecchymosis, scar, inflammation or edema. The presence of tenderness or stiffness will be evaluated by palpation, paying attention to muscle integrity. To the patient group who was applied local vibration; Before injection, local vibration will be applied to the region with a vibrator for five minutes, guided by a previous study on this subject. Afterwards, the skin will be cleaned using 70% alcohol and the injection will be applied with the appropriate technique, and then a light pressure will be applied to the area with a cotton pad for 15-20 seconds. For the patient group treated with ShotBlocker; After skin cleaning, the protruding surface of the vehicle will be placed facing the skin surface and the injection will be applied with the appropriate technique, then ShotBlocker will be removed and a light pressure will be applied to the area with a cotton pad for 15-20 seconds. In the control group; IM injection into the ventrogluteal area will be performed with the appropriate technique without using any tools.
3. Final Assessment:

The change from baseline in pain and satisfaction scores on the Visual Analogue Scale (VAS) will be measured immediately after intramuscular injection using VAS.

Ethical Considerations: The ethical compliance of the study was approved by the Istanbul Medeniyet University Goztepe Training and Research Hospital clinical research ethics committee (date and number: 10.02.2021/0067). Written institutional permission was obtained. After the purpose and duration of the study is explained, written informed consent is obtained from the patients on a voluntary basis.

Statistical Analyses: Data will be analyzed using SPSS (Statistical Package for Social Sciences, Chicago, Illinois) version 16.0.

Note: The research is not supported by any institution or organization.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Injections Pain Satisfaction, Patient

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The sample size was determined as 35 persons for each group at the 0.5 effect size and 0.05 error level with the power analysis performed by taking into account the numerical values of the findings obtained from a previous study on this subject. ShotBlocker group:35; Local vibration group: 35; Control group:35 person
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
The sample of the study consisted of volunteer patients who applied to the adult emergency service, and who were administered antibiotics (amoxicillin / cefuroxime sodium) upon the physician's request, and who met the inclusion criteria of the study.

Criteria for inclusion in the study:

* Being over the age of 18,
* Having no communication problem such as seeing, hearing and understanding problem,
* Having no disease that can cause sensory loss,
* Not having had IM injection in the last week,
* Having no complication related to IM injections such as pain, abscess, infection, tissue necrosis, and hematoma at the injection site.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ShotBlocker

ShotBlocker will be used on 35 patients. For the patient group that is applied ShotBlocker, after cleansing the skin, the protruding surface of the device is placed facing the skin surface. The injection is applied with the appropriate technique, then ShotBlocker is removed and a light pressure is applied to the area with a cotton pad for 15-20 seconds.

Group Type EXPERIMENTAL

Effectiveness of ShotBlocker on the perceived pain and satisfaction during intramuscular antibiotic injection

Intervention Type DEVICE

Intervention: Verbal information was given to the participants prior to the intramuscular injection, and their written consents were obtained. The "Structured Information Form" consisting of five questions was applied by face-to-face interview method. Height and weight were measured, and BMI (kg/m2) was calculated and recorded in the "Structured Information Form".

Application: ShotBlocker will be used on 35 patients during intramuscular injection.

Final assessment: VAS will be applied immediately after the intramuscular injection to determine the pain and satisfaction levels of the participants.

Local Vibration

Local Vibration will be used on 35 patients. For the patient group that was subject to local vibration, local vibration was applied to the region with a vibrator for five minutes prior to injection, following a previous study on this subject. After that, 70% alcohol was used to cleanse the skin. The injection was applied with the appropriate technique, then a light pressure was applied to the area with a cotton pad for 15-20 seconds.

Group Type EXPERIMENTAL

Effectiveness of local vibrator device on the perceived pain and satisfaction during intramuscular antibiotic injection

Intervention Type DEVICE

Intervention: Verbal information was given to the participants prior to the intramuscular injection, and their written consents were obtained. The "Structured Information Form" consisting of five questions was applied by face-to-face interview method. Height and weight were measured, and BMI (kg/m2) was calculated and recorded in the "Structured Information Form".

Application: Local vibrator device will be used on 35 patients during intramuscular injection.

Final assessment: VAS will be applied immediately after the intramuscular injection to determine the pain and satisfaction levels of the participants.

Control

For the control group (n=35), IM injection into the ventrogluteal region without using any tools is performed with the appropriate technique.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Effectiveness of ShotBlocker on the perceived pain and satisfaction during intramuscular antibiotic injection

Intervention: Verbal information was given to the participants prior to the intramuscular injection, and their written consents were obtained. The "Structured Information Form" consisting of five questions was applied by face-to-face interview method. Height and weight were measured, and BMI (kg/m2) was calculated and recorded in the "Structured Information Form".

Application: ShotBlocker will be used on 35 patients during intramuscular injection.

Final assessment: VAS will be applied immediately after the intramuscular injection to determine the pain and satisfaction levels of the participants.

Intervention Type DEVICE

Effectiveness of local vibrator device on the perceived pain and satisfaction during intramuscular antibiotic injection

Intervention: Verbal information was given to the participants prior to the intramuscular injection, and their written consents were obtained. The "Structured Information Form" consisting of five questions was applied by face-to-face interview method. Height and weight were measured, and BMI (kg/m2) was calculated and recorded in the "Structured Information Form".

Application: Local vibrator device will be used on 35 patients during intramuscular injection.

Final assessment: VAS will be applied immediately after the intramuscular injection to determine the pain and satisfaction levels of the participants.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being over the age of 18, Having no communication problem such as seeing, hearing and understanding problem,
* Having no disease that can cause sensory loss,
* Not having had IM injection in the last week, Having no complication related to IM injections such as pain, abscess, infection, tissue necrosis, and hematoma at the injection site.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul Medeniyet University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cemile Savcı

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kurtuluş Açıksarı

Role: STUDY_CHAIR

Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Emergency Medicine Clinic

Alper Solakoğlu

Role: PRINCIPAL_INVESTIGATOR

Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Emergency Medicine Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Emergency Medicine Clinic

Göztepe, Istanbul, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20210067

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

IM İnjection-PAIN-Cold Spray and Stress Ball
NCT07233694 NOT_YET_RECRUITING NA